(Q35693680)

9 August 2017

1 reference

title

The challenge of managing fusariosis (English)

1 reference

9 August 2017

author

Eleftherios Mylonakis

series ordinal

4

object named as

Eleftherios Mylonakis

1 reference

9 August 2017

Maged Muhammed

1

1 reference

9 August 2017

Jeffrey J Coleman

series ordinal

2

1 reference

9 August 2017

Herman A Carneiro

series ordinal

3

1 reference

9 August 2017

publication date

1 March 2011

1 reference

9 August 2017

1 reference

9 August 2017

volume

2

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

91-96

1 reference

Fusarium infection in lung transplant patients: report of 6 cases and review of the literature

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Antifungal therapy in invasive fungal infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Use of Antifungal Combination Therapy: Agents, Order, and Timing

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Emerging infections in burns

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Use of mass spectrometry to identify clinical Fusarium isolates

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Cutaneous Fusarium solani infection in childhood acute lymphoblastic leukaemia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Invasive mold infections: recent advances in management approaches

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Genotypic identification of Fusarium species from ocular sources: comparison to morphologic classification and antifungal sensitivity testing (an AOS thesis).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Update on the treatment of disseminated fusariosis: Focus on voriconazole.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Fusarium infections in immunocompromised patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Posaconazole: a new broad-spectrum antifungal agent

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Voriconazole : a review of its use in the management of invasive fungal infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Posaconazole: clinical pharmacology and potential for management of fungal infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Fusarium infections in critically ill patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

27 July 2018

Emerging fungal diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

The changing face of invasive fungal infections in hematopoietic cell transplant recipients.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Successful Outcome of DisseminatedFusariumInfection with Skin Localization Treated with Voriconazole and Amphotericin B-Lipid Complex in a Patient with Acute Leukemia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Operative treatment of Fusarium fungal infection of the lung

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Fusarium infection in hematopoietic stem cell transplant recipients

27 July 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Invasive fungal infections: a review of epidemiology and management options

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

High genetic diversity and poor in vitro response to antifungals of clinical strains of Fusarium oxysporum

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Combined therapy in treatment of murine infection by Fusarium solani

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Efficacy of liposomal amphotericin B in treatment of systemic murine fusariosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Successful treatment of disseminated fusariosis in a child with acute myelogenous leukaemia with medical and surgical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Myocardial and aortal involvement in a case of disseminated infection with Fusarium solani after allogeneic stem cell transplantation: report of a case.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Treating disseminated fusariosis: amphotericin B, voriconazole or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: an emerging fungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Voriconazole in the management of nosocomial invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Development of a nested PCR assay for the detection of Fusarium solani DNA and its evaluation in the diagnosis of invasive fusariosis using an experimental mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Diagnostic value of DNA and (1-->3)- beta-D-glucan detection in serum and bronchoalveolar lavage of mice experimentally infected with Fusarium oxysporum

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Development of a new MLST scheme for differentiation of Fusarium solani Species Complex (FSSC) isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Species-specific identification of a wide range of clinically relevant fungal pathogens by use of Luminex xMAP technology

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Identification of fungal species by fragment length analysis of the internally transcribed spacer 2 region.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Less-frequent Fusarium species of clinical interest: correlation between morphological and molecular identification and antifungal susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Fusarium infection in burned patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

Case records of the Massachusetts General Hospital. Case 22-2009. A 59-year-old man with skin and pulmonary lesions after chemotherapy for leukemia [corrected].

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Posaconazole in the management of refractory invasive fungal infections

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265755

Successful treatment of catheter-related fusarial infection in immunocompromised children

25 September 2018

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15015

The combination of amphotericin B and azithromycin as a potential new therapeutic approach to fusariosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21304267

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21304267

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21304267

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/VIRU.2.2.15015

1 reference

9 August 2017

1 reference

9 August 2017

1 reference